Gerrard Schmid - Jan 29, 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Signature
Jonathan B. Leiken, Attorney-in-fact for Gerrard Schmid
Stock symbol
DBD
Transactions as of
Jan 29, 2022
Transactions value $
-$523,406
Form type
4
Date filed
1/31/2022, 03:45 PM
Previous filing
Aug 25, 2021
Next filing
Feb 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Tax liability -$344K -39.1K -6.93% $8.80* 525K Jan 29, 2022 Direct F1, F2
transaction DBD Common Shares Tax liability -$179K -20.4K -3.88% $8.80* 505K Jan 30, 2022 Direct F1, F2
holding DBD Common Shares 10K Jan 29, 2022 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Option 192K Jan 29, 2022 Common Shares 192K $15.35 Direct F3
holding DBD Non-Qualified Stock Option 677K Jan 29, 2022 Common Shares 677K $4.49 Direct F4
holding DBD Non-Qualified Stock Option 34.7K Jan 29, 2022 Common Shares 34.7K $13.98 Direct F4
holding DBD Non-Qualified Stock Option 254K Jan 29, 2022 Common Shares 254K $13.15 Direct F4
holding DBD Performance Share Units 56.1K Jan 29, 2022 Common Shares 56.1K Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld pursuant to exercise of tax withholding right under the 2017 Equity and Performance Incentive Plan - Restricted Share Award
F2 Number includes restricted stock units.
F3 Option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F4 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F5 Award subject to a three-year performance period during which the Company's stock price must appreciate at least 25% in order for the grant to vest. Performance will be measured on the anniversaries of the grant date, and the award will vest upon the first achievement of the performance, but will payout in shares on a pro-rata annual basis after performance is satisfied. If the stock performance condition is not met by the third anniversary of the date of grant, then the entire award is forfeited.